Blood test breakthrough could simplify cancer screening for rare genetic disorder
NCT ID NCT06430021
Summary
This study is testing a new blood marker called hPG80 to see if it can help find neuroendocrine tumors earlier in people with a rare inherited condition called MEN1. Currently, people with MEN1 need frequent, stressful scans and tests to check for these tumors. The goal is to see if this simple blood test can be a better, easier way to spot tumors sooner in 297 participants who have the MEN1 gene mutation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chu Dijon Bourgogne
RECRUITINGDijon, 21000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.